What is Nurix Therapeutics, Inc.'s net investment in lease?

Nurix Therapeutics, Inc. (NRIX) reported net investment in lease of $51.66M in Q4 2025.

How has Nurix Therapeutics, Inc.'s net investment in lease changed year-over-year?

Nurix Therapeutics, Inc.'s net investment in lease increased by 96.0% year-over-year, from $26.36M to $51.66M.

What is the long-term trend for Nurix Therapeutics, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s net investment in lease has grown at a 30.5% compound annual growth rate (CAGR), from $13.34M to $50.52M.

Nurix Therapeutics, Inc. NRIX Net Investment in Lease

Net Investment in Lease at other companies

Kymera TherapeuticsKYMR

——

Monte Rosa Therapeutics, Inc.GLUE

——

Stoke Therapeutics, Inc.STOK

——

Viridian Therapeutics, Inc.VRDN

——

Nuvation BioNUVB

——

Celldex TherapeuticsCLDX

——

Segments

By geography

See full

Brisbane, California$5.8M—

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s net investment in lease?: Nurix Therapeutics, Inc. (NRIX) reported net investment in lease of $51.66M in Q4 2025.
How has Nurix Therapeutics, Inc.'s net investment in lease changed year-over-year?: Nurix Therapeutics, Inc.'s net investment in lease increased by 96.0% year-over-year, from $26.36M to $51.66M.
What is the long-term trend for Nurix Therapeutics, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s net investment in lease has grown at a 30.5% compound annual growth rate (CAGR), from $13.34M to $50.52M.